- Home
- PHVS vs IAS Comparison
PHVS vs IAS Comparison
Compare PHVS & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- IAS
- Stock Information
- Founded
- PHVS 2015
- IAS 2009
- Country
- PHVS Switzerland
- IAS United States
- Employees
- PHVS N/A
- IAS N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- IAS Computer Software: Programming Data Processing
- Sector
- PHVS Health Care
- IAS Technology
- Exchange
- PHVS Nasdaq
- IAS Nasdaq
- Market Cap
- PHVS 1.6B
- IAS 1.7B
- IPO Year
- PHVS 2021
- IAS 2021
- Fundamental
- Price
- PHVS $24.95
- IAS $10.25
- Analyst Decision
- PHVS Buy
- IAS Hold
- Analyst Count
- PHVS 7
- IAS 7
- Target Price
- PHVS $37.00
- IAS $12.02
- AVG Volume (30 Days)
- PHVS 282.9K
- IAS 1.4M
- Earning Date
- PHVS 11-12-2025
- IAS 11-04-2025
- Dividend Yield
- PHVS N/A
- IAS N/A
- EPS Growth
- PHVS N/A
- IAS 42.72
- EPS
- PHVS N/A
- IAS 0.28
- Revenue
- PHVS N/A
- IAS $590,666,000.00
- Revenue This Year
- PHVS N/A
- IAS $14.72
- Revenue Next Year
- PHVS N/A
- IAS $11.34
- P/E Ratio
- PHVS N/A
- IAS $36.71
- Revenue Growth
- PHVS N/A
- IAS 15.51
- 52 Week Low
- PHVS $11.51
- IAS $6.26
- 52 Week High
- PHVS $26.33
- IAS $11.78
- Technical
- Relative Strength Index (RSI)
- PHVS 57.14
- IAS 60.66
- Support Level
- PHVS $23.76
- IAS $10.21
- Resistance Level
- PHVS $26.20
- IAS $10.29
- Average True Range (ATR)
- PHVS 1.77
- IAS 0.03
- MACD
- PHVS 0.19
- IAS -0.02
- Stochastic Oscillator
- PHVS 75.19
- IAS 50.00
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.